Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections.
Biomedical device-associated infection is one of the most common and problematic complications faced by millions of patients worldwide. The current antibiotic therapy strategies face challenges, the most serious of which is antibiotic resistance. Studies have shown that the systemic level of interleukin 12 (IL-12) decreases following major injuries resulting in decreased cell-mediated immune response. Here we report the development of IL-12 nanoscale coatings using electrostatic layer-by-layer self-assembly nanotechnology. We found that IL-12 nanoscale coatings at the implant/tissue interface substantially decrease infections in vivo, and IL-12 nanoscale coatings are advantageous over traditional treatments. This approach could be a revolutionary step toward preventing device-associated infections using a non-antibiotic approach.
Li
Bingyun
B
Biomaterials, Bioengineering & Nanotechnology Laboratory, Department of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV 26506-9196, USA. bli@hsc.wvu.edu
Jiang
Bingbing
B
Boyce
Brandon M
BM
Lindsey
Brock A
BA
D000818:Animals; D020811:Biomedical Technology; D004195:Disease Models, Animal; D050723:Fractures, Bone / Q000473:pathology; D006801:Humans; D017053:Infection Control; D018664:Interleukin-12 / Q000737:chemistry* / Q000494:pharmacology; D008855:Microscopy, Electron, Scanning; D049329:Nanostructures / Q000737:chemistry*; D010455:Peptides / Q000737:chemistry*; D051381:Rats; D055672:Static Electricity
D010455:Peptides; D018664:Interleukin-12